Showing 9,521 - 9,540 results of 27,045 for search '(( 50 ((((ng decrease) OR (a decrease))) OR (nn decrease)) ) OR ( 50 n decrease ))', query time: 0.91s Refine Results
  1. 9521

    Table_2_Evaluation of Wearable Technology in Dementia: A Systematic Review and Meta-Analysis.DOC by Alanna C. Cote (9966464)

    Published 2021
    “…Observational studies providing physiological data measured by wearable technology on participants with dementia with a mean age ≥50. Data were extracted according to PRISMA guidelines and methodological quality assessed independently using Downs and Black criteria. …”
  2. 9522

    Table_1_Evaluation of Wearable Technology in Dementia: A Systematic Review and Meta-Analysis.DOC by Alanna C. Cote (9966464)

    Published 2021
    “…Observational studies providing physiological data measured by wearable technology on participants with dementia with a mean age ≥50. Data were extracted according to PRISMA guidelines and methodological quality assessed independently using Downs and Black criteria. …”
  3. 9523

    Table_2_Evaluation of Wearable Technology in Dementia: A Systematic Review and Meta-Analysis.DOC by Alanna C. Cote (9966464)

    Published 2021
    “…Observational studies providing physiological data measured by wearable technology on participants with dementia with a mean age ≥50. Data were extracted according to PRISMA guidelines and methodological quality assessed independently using Downs and Black criteria. …”
  4. 9524

    Table_1_Evaluation of Wearable Technology in Dementia: A Systematic Review and Meta-Analysis.DOC by Alanna C. Cote (9966464)

    Published 2021
    “…Observational studies providing physiological data measured by wearable technology on participants with dementia with a mean age ≥50. Data were extracted according to PRISMA guidelines and methodological quality assessed independently using Downs and Black criteria. …”
  5. 9525
  6. 9526
  7. 9527
  8. 9528
  9. 9529
  10. 9530

    The Effect of Dosing Regimens on the Antimalarial Efficacy of Dihydroartemisinin-Piperaquine: A Pooled Analysis of Individual Patient Data by The WorldWide Antimalarial Resistance Network (WWARN) DP Study Group (614261)

    Published 2013
    “…After adjusting for confounding factors, the mg/kg dose of piperaquine was found to be a significant predictor for recrudescence, the risk increasing by 13% (95% CI 5.0%–21%) for every 5 mg/kg decrease in dose; <i>p</i> = 0.002. …”
  11. 9531
  12. 9532
  13. 9533
  14. 9534
  15. 9535
  16. 9536
  17. 9537
  18. 9538
  19. 9539
  20. 9540